These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36951406)

  • 41. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa.
    Pillay D; Stankevitz K; Lanham M; Ridgeway K; Murire M; Briedenhann E; Jenkins S; Subedar H; Hoke T; Mullick S
    PLoS One; 2020; 15(4):e0228620. PubMed ID: 32352969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with Men.
    Biello KB; Hosek S; Drucker MT; Belzer M; Mimiaga MJ; Marrow E; Coffey-Esquivel J; Brothers J; Mayer KH
    Arch Sex Behav; 2018 Oct; 47(7):2101-2107. PubMed ID: 28929260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PrEP reminds me that I am the one to take responsibility of my life: a qualitative study exploring experiences of and attitudes towards pre-exposure prophylaxis use by women in Eswatini.
    Bjertrup PJ; Mmema N; Dlamini V; Ciglenecki I; Mpala Q; Matse S; Kerschberger B; Wringe A
    BMC Public Health; 2021 Apr; 21(1):727. PubMed ID: 33853575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring the feasibility and acceptability of integrating screening for gender-based violence into HIV counselling and testing for adolescent girls and young women in Tanzania and South Africa.
    Colombini M; Scorgie F; Stangl A; Harvey S; Ramskin L; Khoza N; Mashauri E; Baron D; Lees S; Kapiga S; Watts C; Delany-Moretlwe S;
    BMC Public Health; 2021 Mar; 21(1):433. PubMed ID: 33658000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
    Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
    Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing acceptability of pre-exposure prophylaxis (PrEP) among participants in an HIV vaccine preparedness study in southwestern Uganda.
    Nakamanya S; Kawuma R; Kibuuka D; Kusemererwa S; McCormack S; Ruzagira E; Seeley J;
    PLoS One; 2022; 17(7):e0271104. PubMed ID: 35905052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.
    Govender EM; Mansoor LE; Abdool Karim Q
    AIDS Care; 2017 Jun; 29(6):734-740. PubMed ID: 27799005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Providers' Attitudes and Experiences with Pre-Exposure Prophylaxis Implementation in a Population-Based Study in Kenya and Uganda.
    Camlin CS; Getahun M; Koss CA; Owino L; Akatukwasa C; Itiakorit H; Onyango A; Bakanoma R; Atwine F; Maeri I; Ayieko J; Atukunda M; Owaraganise A; Mwangwa F; Sang N; Kabami J; Kaplan RL; Chamie G; Petersen ML; Cohen CR; Bukusi EA; Kamya MR; Havlir DV; Charlebois ED
    AIDS Patient Care STDS; 2022 Oct; 36(10):396-404. PubMed ID: 36201226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe.
    Dietrich JJ; Ahmed N; Webb EL; Tshabalala G; Hornschuh S; Mulaudzi M; Atujuna M; Stranix-Chibanda L; Nematadzira T; Ssemata AS; Muhumuza R; Seeley J; Bekker LG; Weiss HA; Martinson N; Fox J;
    J Int AIDS Soc; 2022 Aug; 25(8):e25975. PubMed ID: 36002910
    [TBL] [Abstract][Full Text] [Related]  

  • 50. "I am still negative": Female sex workers' perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa.
    Eakle R; Bothma R; Bourne A; Gumede S; Motsosi K; Rees H
    PLoS One; 2019; 14(4):e0212271. PubMed ID: 30964874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Provider perspectives on service delivery modifications to maintain access to HIV pre-exposure prophylaxis during the COVID-19 pandemic: qualitative results from a PrEP implementation project in Kenya.
    Velloza J; Roche SD; Owidi EJ; Irungu EM; Dollah A; Kwach B; Thuo NB; Morton JF; Mugo N; Bukusi EA; O'Malley G; Ngure K; Baeten JM; Mugwanya KK;
    J Int AIDS Soc; 2023 Feb; 26(2):e26055. PubMed ID: 36739603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improving access to pre-exposure prophylaxis for adolescent girls and young women: recommendations from healthcare providers in eastern Zimbabwe.
    Skovdal M; Magoge-Mandizvidza P; Dzamatira F; Maswera R; Nyamukapa C; Thomas R; Mugurungi O; Gregson S
    BMC Infect Dis; 2022 Apr; 22(1):399. PubMed ID: 35461220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Women's Perceptions of HIV- and Sexuality-Related Stigma in Relation to PrEP: Qualitative Findings from the Masibambane Study, Durban, South Africa.
    Bergam S; Harrison AD; Benghu N; Khumalo S; Tesfay N; Exner T; Miller L; Dolezal C; Hanass-Hancock J; Hoffman S
    AIDS Behav; 2022 Sep; 26(9):2881-2890. PubMed ID: 35218452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "Emotional stress is more detrimental than the virus itself": A qualitative study to understand HIV testing and pre-exposure prophylaxis (PrEP) use among internal migrant men in South Africa.
    Nardell MF; Govathson-Mandimika C; Garnier S; Watts A; Babalola D; Ngcobo N; Long L; Lurie MN; Miot J; Pascoe S; Katz IT
    J Int AIDS Soc; 2024 Mar; 27(3):e26225. PubMed ID: 38462755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Community perspectives on addressing and responding to HIV-testing, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) among African, Caribbean and Black (ACB) people in Ontario, Canada.
    Etowa J; Tharao W; Mbuagbaw L; Baidoobonso S; Hyman I; Obiorah S; Aden M; Etowa EB; Gebremeskel A; Kihembo M; Nelson L; Husbands W
    BMC Public Health; 2022 May; 22(1):913. PubMed ID: 35525946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Barriers and Facilitators to Long-Acting Injectable HIV Pre-Exposure Prophylaxis Implementation in Primary Care Since Its Approval in the United States.
    Keddem S; Thatipelli S; Caceres O; Roder N; Momplaisir F; Cronholm P
    J Acquir Immune Defic Syndr; 2024 Apr; 95(4):370-376. PubMed ID: 38133586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. "Being able to do whatever you wanna do as a woman is important:" a qualitative exploration of contraception as a frame of reference for HIV prevention with PrEP.
    Murphy EC; Danvers A; Zamudio AR; Avila K; Proehl M; Gonzalez-Argoti T; Mantell JE; Bauman LJ; Dolan SM
    Reprod Health; 2022 Apr; 19(1):92. PubMed ID: 35392943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "I had Made the Decision, and No One was Going to Stop Me" -Facilitators of PrEP Adherence During Pregnancy and Postpartum in Cape Town, South Africa.
    Joseph Davey DL; Knight L; Markt-Maloney J; Tsawe N; Gomba Y; Mashele N; Dovel K; Gorbach P; Bekker LG; Coates TJ; Myer L
    AIDS Behav; 2021 Dec; 25(12):3978-3986. PubMed ID: 34085132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives.
    Sun CJ; Anderson KM; Bangsberg D; Toevs K; Morrison D; Wells C; Clark P; Nicolaidis C
    J Gen Intern Med; 2019 Apr; 34(4):535-543. PubMed ID: 30719647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Barriers and Facilitators to Pre-exposure Prophylaxis Uptake Among Black Women: A Qualitative Analysis Guided by a Socioecological Model.
    D'Angelo AB; Davis Ewart LN; Koken J; Bimbi D; Brown JT; Grov C
    J Assoc Nurses AIDS Care; 2021 Jul-Aug 01; 32(4):481-494. PubMed ID: 34171885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.